Catherine M. Burzik - 19 Jun 2023 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)

Role
Director
Signature
/s/ Patrick Keran, attorney-in-fact
Issuer symbol
OFIX
Transactions as of
19 Jun 2023
Net transactions value
$0
Form type
4
Filing time
21 Jun 2023, 16:18:37 UTC
Previous filing
26 Jan 2023
Next filing
17 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OFIX Common Stock Award $0 +3,589 +10% $0.000000 37,949 19 Jun 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of deferred stock units that vest in full on the earlier of (i) June 30, 2024 or (ii) the date on which the issuer holds its 2024 annual meeting of stockholders, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.
F2 Includes 32,763 deferred stock units.
F3 Includes 1,304 shares purchased by the reporting person, on April 30, 2023, under the Orthofix Medical Inc. Second Amended and Restated Stock Purchase Plan, in a transaction exempt under Rule 16b-3(c).